U.S. invests $170 million in late-stage Ebola vaccines, drugs
CHICAGO (Reuters) - The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Administration.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Ebola | Ebola Vaccine | Food and Drug Administration (FDA) | Government | Health | Vaccines